India's Jubilant Life Sciences Ltd said on Tuesday it had signed a non-exclusive licensing agreement for selling Gilead Sciences Inc's experimental COVID-19 treatment remdesivir in 127 countries,...
Home »
NDTV News - India-news
» India's Jubilant Signs Licensing Deal For US Pharma Firm's COVID-19 Drug
No comments:
Post a Comment